Selection of aptamers in SELEX process

Toxicology and Environmental Health Sciences

Volumn 1, Issue 1, 2009, Pages 1-7

  Ahn, Ji Young ^a   Kim, Eunkyung ^a   Ryu, Jae Chun ^b   Kim, Soyoun ^a  

^a Dongguk University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79954615399     PISSN: 20059752     EISSN: 22337784     Source Type: Journal    
DOI: 10.1007/BF03216457     Document Type: Review

References (55)

1. Ellington, A. D. & Szostak, J. W. In vitro selection of RNA molecules that bind specific ligands. Nature346, 818-822 (1990).
2. Tuerk, C. & Gold, L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science New York, N. Y. 249, 505-510 (1990).
3. Kramer, F. R., Mills, D. R., Cole, P. E., Nishihara, T. & Spiegelman, S. Evolution in vitro: Sequence and phenotype of a mutant RNA resistant to ethidium bromide. Journal of Molecular Biology89, 719-736 (1974).
4. Ellington, A. D. RNA selection. Aptamers achieve the desired recognition. Curr Biol4, 427-429 (1994).
5. Dobbelstein, M. & Shenk, T. In vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by using randomized and cDNA-derived RNA libraries. Journal of Virology69, 8027-8034 (1995).
6. Conrad, R. C., Giver, L., Tian, Y. & Ellington, A. D. In vitro selection of nucleic acid aptamers that bind proteins. Methods in Enzymology267, 336-367 (1996).
7. Bruno, J. G. & Kiel, J. L. Use of magnetic beads in selection and detection of biotoxin aptamers by electrochemiluminescence and enzymatic methods. Bio-Techniques32, 178-180, 182-173 (2002).
8. Nimjee, S. M., Rusconi, C. P. & Sullenger, B. A. Aptamers: An emerging class of therapeutics. Annual Review of Medicine56, 555-583 (2005).
9. Gold, L. Oligonucleotides as research, diagnostic, and therapeutic agents. The Journal of Biological Chemistry270, 13581-13584 (1995).
10. Marshall, K. A. & Ellington, A. D. In vitro selection of RNA aptamers. Methods in Enzymology318, 193-214 (2000).
11. Tracy, R. B. & Kowalczykowski, S. C. In vitro selection of preferred DNA pairing sequences by the Escherichia coli RecA protein. Genes & Development10, 1890-1903 (1996).
12. Mendonsa, S. D. & Bowser, M. T. In vitro evolution of functional DNA using capillary electrophoresis. Journal of the American Chemical Society126, 20-21 (2004).
13. Mosing, R. K., Mendonsa, S. D. & Bowser, M. T. Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase. Analytical Chemistry77, 6107-6112 (2005).
14. Berezovski, M. V., Musheev, M. U., Drabovich, A. P., Jitkova, J. V. & Krylov, S. N. Non-SELEX: Selection of aptamers without intermediate amplification of candidate oligonucleotides. Nature Protocols1, 1359-1369 (2006).
15. Berezovski, M., Nutiu, R., Li, Y. & Krylov, S. N. Affinity analysis of a protein-aptamer complex using nonequilibrium capillary electrophoresis of equilibrium mixtures. Analytical Chemistry75, 1382-1386 (2003).
16. Fujita, K. & Silver, J. Surprising lability of biotin-streptavidin bond during transcription of biotinylated DNA bound to paramagnetic streptavidin beads. BioTechniques14, 608-617 (1993).
17. Shepard, A. R. & Rae, J. L. Magnetic bead capture of cDNAs from double-stranded plasmid cDNA libraries. Nucleic Acids Research25, 3183-3185 (1997).
18. Smistrup, K. et al. On-chip magnetic bead microarray using hydrodynamic focusing in a passive magnetic separator. Lab on a Chip5, 1315-1319 (2005).
19. Stoltenburg, R., Reinemann, C. & Strehlitz, B. Flu-Mag-SELEX as an advantageous method for DNA aptamer selection. Analytical and Bioanalytical Chemistry383, 83-91 (2005).
20. Yang, X. et al. Construction and selection of beadbound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries designed for rapid PCR-based sequencing. Nucleic Acids Research30, e132 (2002).
21. Yang, X. et al. Immunofluorescence assay and flowcytometry selection of bead-bound aptamers. Nucleic Acds Research31, e54 (2003).
22. Tok, J. B. & Fischer, N. O. Single microbead SELEX for efficient ssDNA aptamer generation against botulinum neurotoxin. Chemical Communications (Cambridge, England)16, 1883-1885 (2008).
23. Rhie, A. et al. Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. The Journal of Biological Chemistry278, 39697-39705 (2003).
24. Homann, M., Lorger, M., Engstler, M., Zacharias, M. & Goringer, H. U. Serum-stable RNA aptamers to an invariant surface domain of live African trypanosomes. Combinatorial Chemistry & High Throughput Screening9, 491-499 (2006).
25. Dykman, L. A., Bogatyrev, V. A., Khlebtsov, B. N. & Khlebtsov, N. G. A protein assay based on colloidal gold conjugates with trypsin. Analytical Biochemistry341, 16-21 (2005).
26. Kaur, R. & Raje, M. A solid-phase method for evaluation of gold conjugate used in quantitative detection of antigen by immunogold-labeling electron microscopy. Journal of Immunological Methods279, 33-40 (2003).
27. Cao, Y. C., Jin, R. & Mirkin, C. A. Nanoparticles with Raman spectroscopic fingerprints for DNA and RNA detection. Science New York, N. Y. 297, 1536-1540 (2002).
28. Moreno, M. et al. Selection of aptamers against KMP-11 using colloidal gold during the SELEX process. Biochemical and Biophysical Research Communications308, 214-218 (2003).
29. Huang, C. C., Huang, Y. F., Cao, Z., Tan, W. & Chang, H. T. Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors. Analytical Chemistry77, 5735-5741 (2005).
30. Morris, K. N., Jensen, K. B., Julin, C. M., Weil, M. & Gold, L. High affinity ligands from in vitro selection: Complex targets. Proceedings of the National Academy of Sciences of the United States of America95, 2902-2907 (1998).
31. Blank, M., Weinschenk, T., Priemer, M. & Schluesener, H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. The Journal of Biological Chemistry276, 16464-16468 (2001).
32. Daniels, D. A., Chen, H., Hicke, B. J., Swiderek, K. M. & Gold, L. A tenascin-C aptamer identified by tumor cell SELEX: Systematic evolution of ligands by exponential enrichment. Proceedings of the National Academy of Sciences of the United States of America100, 15416-15421 (2003).
33. Shangguan, D. et al. Aptamers evolved from live cells as effective molecular probes for cancer study. Proceedings of the National Academy of Sciences of the United States of America103, 11838-11843 (2006).
34. Luo, J., Isaacs, W. B., Trent, J. M. & Duggan, D. J. Looking beyond morphology: Cancer gene expression profiling using DNA microarrays. Cancer Investigation21, 937-949 (2003).
35. Espina, V. et al. Pathology of the future: Molecular profiling for targeted therapy. Cancer Investigation23, 36-46 (2005).
36. Tang, Z. et al. Selection of aptamers for molecular recognition and characterization of cancer cells. Analytical Chemistry79, 4900-4907 (2007).
37. Cerchia, L. et al. Neutralizing aptamers from wholecell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biology3, e123 (2005).
38. Hicke, B. J. et al. Tumor targeting by an aptamer. J Nucl Med47, 668-678 (2006).
39. Smith, J. E. et al. Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells. Analytical Chemistry79, 3075-3082 (2007).
40. Gill, I. & Ballesteros, A. Bioencapsulation within synthetic polymers (Part 1): Sol-gel encapsulated biologicals. Trends in Biotechnology18, 282-296 (2000).
41. Gill, I. & Ballesteros, A. Novel sol-gel matrices for the immobilization of enzymes. Annals of the New York Academy of Sciences799, 697-700 (1996).
42. Reetz, M. T., Zonta, A. & Simpelkamp, J. Efficient immobilization of lipases by entrapment in hydrophobic sol-gel materials. Biotechnology and Bioengineering49, 527-534 (1996).
43. Kim, Y. Y., Chae, S. Y., Kim, S., Byun, Y. & Bae, Y. H. Improved phenotype of rat islets in a macrocapsule by co-encapsulation with cross-linked Hb. Journal of Biomaterials Science16, 1521-1535 (2005).
44. Lee, S. et al. Chip-based detection of hepatitis C virus using RNA aptamers that specifically bind to HCV core antigen. Biochemical and Biophysical Research Communications358, 47-52 (2007).
45. Pastor, I., Ferrer, M. L., Lillo, M. P., Gomez, J. & Mateo, C. R. Structure and dynamics of lysozyme encapsulated in a silica sol-gel matrix. The Journal of Physical Chemistry111, 11603-11610 (2007).
46. Ahn, J. Y. et al. Sol-gel material optimization for aptamer biosensors. Molecular and Cellular Toxicology4, 100-105 (2008).
47. Park, S. et al. Selection and elution of aptamers using nanoporous sol-gel arrays with integrated microheaters. Lap on a Chip9, 1206-1212 (2009).
48. Lee, S. & Kim, S. Improvement of protein chip sensitivity by increasing salt concentration. Biochip Journal1, 107-110 (2007).
49. Cox, J. C., Rudolph, P. & Ellington, A. D. Automated RNA selection. Biotechnology Progress14, 845-850 (1998).
50. Cox, J. C. & Ellington, A. D. Automated selection of anti-protein aptamers. Bioorganic & Medicinal Chemistry9, 2525-2531 (2001).
51. Wochner, A., Cech, B., Menger, M., Erdmann, V. A. & Glokler, J. Semi-automated selection of DNA aptamers using magnetic particle handling. BioTechniques43, 344, 346, 348 passim (2007).
52. Eulberg, D., Buchner, K., Maasch, C. & Klussmann, S. Development of an automated in vitro selection protocol to obtain RNA-based aptamers: Identification of a biostable substance P antagonist. Nucleic Acids Research33, e45 (2005).
53. Craighead, H. Future lab-on-a-chip technologies for interrogating individual molecules. Nature442, 387-393 (2006).
54. Gopinath, S. Methods developed for SELEX. Analytical and Bioanalytical Chemistry387, 171-182 (2007).
55. Hybarger, G., Bynum, J., Williams, R. F., Valdes, J. J. & Chambers, J. P. A microfluidic SELEX prototype. Analytical and Bioanalytical Chemistry384, 191-198 (2006).